GE HealthCare Technologies Inc. (GEHC)

GE HealthCare Technologies Inc., headquartered in Chicago, Illinois, is a global healthcare solutions provider specializing in advanced medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions, employing approximately 54,000 colleagues (32% U.S.-based) and serving customers in over 160 countries through roughly 9,700 sales professionals and 8,900 field service engineers. The company, a Delaware corporation, was spun off from General Electric (now GE Aerospace) on January 3, 2023, and operates with nearly 130 years of industry history. GE HealthCare generates revenue from medical devices, consumables, service capabilities, and AI-enabled cloud/software solutions across four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

The Imaging segment covers Molecular Imaging, Computed Tomography, Magnetic Resonance, Women's Health, and X-ray product lines supporting oncology, cardiology, neurology, and other clinical specialties. AVS focuses on Specialized Ultrasound (Comprehensive Care and Women's Health Ultrasound) and Procedural Guidance (CardioVascular/Interventional Solutions and Surgical Innovations). PCS serves Monitoring Solutions (Patient Monitoring, Diagnostic Cardiology) and Life Support Solutions (Maternal Infant Care, Anesthesia), along with consumables and digital solutions generating recurring revenue.

PDx supplies contrast media and radiopharmaceutical imaging agents used in diagnostic imaging, complementing the company's equipment offerings. The company employs approximately 11,100 engineers and scientists in R&D, maintains a substantial intellectual property portfolio, and operates 44 manufacturing/pharmaceutical facilities across 17 countries. Primary competitors include Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, and Canon in medical technology, and Bayer, Bracco, Guerbet, and Curium in pharmaceutical diagnostics.

The company faces extensive global regulation from bodies including the FDA, EMA, and NMPA, along with data privacy laws such as HIPAA, GDPR, and China's PIPL, as well as healthcare fraud, anti-kickback, and anti-corruption laws including the FCA and FCPA. GE HealthCare's strategy includes acquisitions to expand its portfolio, a sustainability program addressing healthcare access, workforce well-being, and product lifecycle sustainability, and a leadership team headed by CEO Peter J. Arduini, supported by executives overseeing finance, segments, legal, technology, and human resources.